Golden Metal Resources Aktie 126504846 / GB00BPQY8R36
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
29.10.2025 08:00:03
|
EQS-News: Final Results
|
EQS-News: Guardian Metal Resources plc
/ Key word(s): Annual Results
Guardian Metal Resources plc ('Guardian Metal' or the 'Company')
Audited Financial Results for the Year Ended 30 June 2025
Guardian Metal Resources plc (LON:GMET/OTCQB:GMTLF), a tungsten exploration and development company focused on Nevada, U.S. is pleased to announce its consolidated audited results for the year ended 30 June 2025, for the Company and its subsidiaries (together, the "Group").
The full financial report will be available online immediately on the Company's website, and should be read in conjunction with this announcement.
Highlights from the year under review:
Corporate Developments
Financial Highlights The Group incurred a loss for the year to 30 June 2025 of $2,711,000 (2024 – loss of $1,376,000). The loss mainly arose from salaries, consulting and professional fees along with general regulatory and administration expenses.
Cash used in operations totalled $1,122,000 and investment in its mining assets totalled $8,038,000 (2024 - $1,496,000). As at 30 June 2025, the Group had a cash balance of $1,873,000 (2024 - $3,033,000). At the date of this announcement, the Group’s cash balance was $14,720,000.
Funding Activities During the year under review a total of 18,908,700 warrants over new ordinary shares were exercised raising $4,455,305 (£3,414,479) for the Company. The Company also completed strategic fundraises issuing in total 10,478,054 new ordinary shares, raising $3,677,988 (£2,904,075) before costs for the Company.
Subsequent to reporting date on 23 July 2025, the Company completed a fundraise of $21,000,000 (approximately £15,600,000) before costs through the issue of 25,945,000 new ordinary shares to new and existing shareholders. On the same date the Company also announced that its wholly owned subsidiary Golden Metal Resources (USA) LLC had been awarded $6.2 million from the U.S. Department of War (DoW) to accelerate the development of its Pilot Mountain Project.
Board of Directors We welcomed Ben Hodges who joined the Company as Finance Director on 12 December 2024. David Ovadia, Non-Executive Chairman, resigned from the Board on 11 December 2024. The Board takes this opportunity to thank David for his contribution to the Company over his tenure. Non-Executive Director J.T. Starzecki assumed the position of Non-Executive Chairman with effect from 11 December 2024, and in June 2025 Mr. Starzecki accepted the role of Executive Chairman.
Events after the year end
For information regarding events after the reporting date see note 19 to the financial statements.
Outlook:
Looking ahead, Guardian Metal’s priorities are clear: advance Pilot Mountain and Tempiute through the next stage of technical and economic studies, supported by the financing, partnerships, and contractor base secured this year. With two co-flagship assets in Nevada, an increasingly engaged U.S. investor base and growing recognition across industry and government, Guardian Metal is well positioned to deliver on its ambition of becoming America’s next tungsten producer. We also have announced that we plan to pursue a USA listing.
I would like to thank our shareholders, partners, and team for their ongoing support and commitment. Together, we are building a company that can play a pivotal role in delivering secure domestic supply of this critical mineral for defence, energy transition, and high-technology applications.
Oliver Friesen, Chief Executive Officer 28 October 2025
Click on, or paste the following link into your web browser, to view the full announcement. http://www.rns-pdf.londonstockexchange.com/rns/1923F_1-2025-10-28.pdf
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
For further information visit www.guardianmetalresources.com or contact the following:
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
29.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
2220166 29.10.2025 CET/CEST
Nachrichten zu Golden Metal Resources PLC Registered Shs
|
11.11.25 |
EQS-News: Board Update (EQS Group) | |
|
03.11.25 |
EQS-News: Garfield Project Exploration Update (EQS Group) | |
|
03.11.25 |
EQS-News: Board Changes (EQS Group) | |
|
29.10.25 |
EQS-News: Final Results (EQS Group) | |
|
23.10.25 |
EQS-News: Change of Broker (EQS Group) | |
|
23.10.25 |
EQS-News: Tempiute Project Operational Update (EQS Group) | |
|
29.09.25 |
EQS-News: Pilot North: Very-High Grade Assay Results (EQS Group) | |
|
08.09.25 |
EQS-News: Intention to list in the US (EQS Group) |
Analysen zu Golden Metal Resources PLC Registered Shs
Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest
Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.
Schnell noch Plätze sichern!Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer
Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉
Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.
💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Warten auf anstehende Datenflut: Dow schlussendlich stark -- SMI letztlich fester -- DAX schliesslich freundlich -- Märkte in Fernost enden uneinheitlichSowohl der heimische als auch der deutsche Aktienmarkt präsentierten sich am Dienstag fester. Der US-Aktienmarkt bewegte sich am Dienstag in unterschiedliche Richtungen. Die wichtigsten asiatischen Börsen zeigten sich am Dienstag uneins.


